ArticleCase reports in gastroenterology

Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab.

Tsutomu Mizoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.